Ketamine for Treatment-Resistant Unipolar Depression

Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years

(2011) Sidney H. Kennedy et al.   AMERICAN JOURNAL OF PSYCHIATRY

Reply to: Dose- and Exposure-Response to Ketamine in Depression

(2011) James W. Murrough et al.   BIOLOGICAL PSYCHIATRY

Dose- and Exposure-Response to Ketamine in Depression

(2011) Paul Glue et al.   BIOLOGICAL PSYCHIATRY

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

(2011) Gregory Luke Larkin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Case of Sustained Remission Following an Acute Course of Ketamine in Treatment-Resistant Depression

(2011) James W. Murrough et al.   JOURNAL OF CLINICAL PSYCHIATRY

Ketamine Alleviates Fear, Depression, and Suicidal Ideation in Terminally Ill Patients

(2011) Duraiyah Thangathurai et al.   JOURNAL OF PALLIATIVE MEDICINE

Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies

(2011) James W. Murrough et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

(2011) Lobna Ibrahim et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

(2011) Gerald W. Valentine et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Linking Molecules to Mood: New Insight Into the Biology of Depression

(2010) Vaishnav Krishnan et al.   AMERICAN JOURNAL OF PSYCHIATRY

Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder

(2010) Mark S. George et al.   ARCHIVES OF GENERAL PSYCHIATRY

Therapeutic Options for Treatment-Resistant Depression

(2010) Richard C. Shelton et al.   CNS DRUGS

Ketamine for the treatment of chronic non-cancer pain

(2010) Ingeborg Noppers et al.   EXPERT OPINION ON PHARMACOTHERAPY

Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder

(2010) Nancy DiazGranados et al.   JOURNAL OF CLINICAL PSYCHIATRY

Acute and Sustained Effects of Cognitive Emotion Regulation in Major Depression

(2010) S. Erk et al.   JOURNAL OF NEUROSCIENCE

Schizophrenia: The drug deadlock

(2010) Alison Abbott   NATURE

Cracking the moody brain: Lifting the mood with ketamine

(2010) James W Murrough et al.   NATURE MEDICINE

ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses

(2010) Vincent Vialou et al.   NATURE NEUROSCIENCE

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

(2010) Giacomo Salvadore et al.   NEUROPSYCHOPHARMACOLOGY

Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response

(2010) Diego A Pizzagalli   NEUROPSYCHOPHARMACOLOGY

Nuclear factor- B is a critical mediator of stress-impaired neurogenesis and depressive behavior

(2010) J. W. Koo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study

(2009) Celia J. A. Morgan et al.   ADDICTION

Effect of Concomitant Pharmacotherapy on Electroconvulsive Therapy Outcomes

(2009) Harold A. Sackeim et al.   ARCHIVES OF GENERAL PSYCHIATRY

Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression

(2009) Rebecca B. Price et al.   BIOLOGICAL PSYCHIATRY

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain

(2009) Volker Huge et al.   EUROPEAN JOURNAL OF PAIN

Use of oral ketamine in chronic pain management: A review

(2009) Maren I. Blonk et al.   EUROPEAN JOURNAL OF PAIN

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

(2009) Sanjay J. Mathew et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression

(2009) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine

(2009) X. Chen et al.   JOURNAL OF NEUROSCIENCE

Neurocircuitry of Mood Disorders

(2009) Joseph L Price et al.   NEUROPSYCHOPHARMACOLOGY

The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders

(2009) Rodrigo Machado-Vieira et al.   NEUROSCIENTIST

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study

(2009) Robert J. Schwartzman et al.   PAIN

What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression

(2009) Bradley Gaynes et al.   PSYCHIATRIC SERVICES

Dopamine D2Highreceptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil

(2009) Philip Seeman et al.   SYNAPSE

Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine

(2008) Giacomo Salvadore et al.   BIOLOGICAL PSYCHIATRY

Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder

(2008) Rebecca B. Price et al.   BIOLOGICAL PSYCHIATRY

Treatment-resistant depression: recent developments and future directions

(2008) Sanjay J. Mathew   DEPRESSION AND ANXIETY

S-ketamine and GABA-A-receptor interaction in humans: an exploratory study with I-123-iomazenil SPECT

(2008) Alexander Heinzel et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

(2008) Sheldon H. Preskorn et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

(2008) Gerard Sanacora et al.   NATURE REVIEWS DRUG DISCOVERY

Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial

(2008) Sarah H Lisanby et al.   NEUROPSYCHOPHARMACOLOGY

Novel Drugs and Therapeutic Targets for Severe Mood Disorders

(2008) Sanjay J Mathew et al.   NEUROPSYCHOPHARMACOLOGY

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

(2008) Michael Liebrenz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases

(2008) Robert Paul et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

(2007) Sungho Maeng et al.   BIOLOGICAL PSYCHIATRY

Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons

(2005) Martin Weber et al.   BRITISH JOURNAL OF PHARMACOLOGY